Zydus Lifesciences Limited has informed the Exchange regarding a press release dated November 06, 2023, titled "Zydus receives USFDA approval for ZITUVIMETTM to treat adult patients with type 2 diabetes mellitus".
Zydus Lifesciences Limited Press Release Nov 06 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Nov 03 2023
- Press Release Nov 02 2023
- Press Release Oct 31 2023
- Press Release Oct 30 2023
- Press Release Oct 25 2023
Later from Zydus Lifesciences
- Press Release Nov 07 2023
- Press Release Nov 10 2023
- Press Release Dec 01 2023
- Zydus Lifesciences Limited Press Release Dec 06 2023
- Zydus Lifesciences Limited Press Release Dec 11 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences